Biotech

All Articles

Lykos will ask FDA to rethink its selection observing rejection of MDMA treatment for trauma

.Complying with a bad showing for Lykos Therapies' MDMA prospect for post-traumatic stress disorder ...

AN 2 halves headcount, quits period 3 test after records disappoint

.AN2 Rehabs is re-thinking its service in action to lackluster midphase records, vowing to lay off h...

Merck pays out $700M for bispecific, snooping autoimmune opening and also opportunity to challenge Amgen in cancer

.Merck &amp Co. is actually paying out $700 thousand ahead of time to challenge Amgen in a blood can...

Gilead pays J&ampJ $320M to exit licensing deal for seladelpar

.Along With Gilead Sciences almost an FDA selection for its liver ailment medication seladelpar, the...

' All palms on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks can observe the providers putting together tents at basecamp re...

Entero laying off team, abandoning office and also pausing R&ampD

.Bed Liquidators has actually turned Entero Rehabs white colored as a sheet. The lender bought Enter...

Exelixis loses ADC after determining it's no suit for Tivdak

.Exelixis is losing hope on its own cells element (TF)- targeting antibody-drug conjugate after wrap...

Relay loses interest in SHP2 prevention after Genentech leaves

.3 weeks after Roche's Genentech system ignored an SHP2 inhibitor contract, Relay Therapeutics has a...

Stoke's Dravet disorder med launched of predisposed scientific hold

.Stoke Therapeutics' Dravet disorder drug has actually been freed from a predisposed hold, removing ...

Fierce Biotech's Gabrielle Masson presents Strong 15 at NYSE

.Brutal Biotech Colleague Publisher Gabrielle Masson offered the 2024 lesson of Brutal 15 winners on...